StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
AGM/EGMJun 10, 2026, 04:13 PM

enGene Holdings Shareholders Elect Directors, Appoint Auditor

AI Summary

enGene Holdings Inc. held its 2026 Annual General Meeting on June 9, 2026. A total of 56,196,302 common shares, representing approximately 83.89% of outstanding shares, were present or represented by proxy. Shareholders voted to elect all four director nominees and approved the appointment and remuneration of the auditor.

Key Highlights

  • Shareholders elected Philip Astley-Sparke with 47,112,414 votes For.
  • Ronald H.W. Cooper was elected with 47,329,848 votes For.
  • Dr. William Grossman received 47,408,163 votes For his election.
  • Michael Heffernan was elected with 47,408,163 votes For.
  • The appointment and remuneration of the auditor received 56,180,287 votes For.
  • Approximately 83.89% of common shares were present or represented at the meeting.